MBX-500

N/A

Report date: 2026/03/06 20:02:51
NME

Base Information

Drug NameMBX-500
Drug Alias Name259CMBX-259CMBX-500MBX-251D251D
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibiotics
Mechanisms of ActionBacterial DNA gyrase inhibitorsTopoisomerase IV inhibitorsDNA-directed DNA polymerase inhibitors
TargetsBacterial DNA gyraseTopoisomerase IVDNA-directed DNA polymerase
Therapy Area/IndicationsClostridium Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMicrobiotix IncGlsynthesis Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsClostridium Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A